Microbial Metabolite Dysbiosis and Colorectal Cancer
- PMID: 36632785
- PMCID: PMC10018301
- DOI: 10.5009/gnl220260
Microbial Metabolite Dysbiosis and Colorectal Cancer
Abstract
The global burden of colorectal cancer (CRC) is expected to continuously increase. Through research performed in the past decades, the effects of various environmental factors on CRC development have been well identified. Diet, the gut microbiota and their metabolites are key environmental factors that profoundly affect CRC development. Major microbial metabolites with a relevance for CRC prevention and pathogenesis include dietary fiber-derived short-chain fatty acids, bile acid derivatives, indole metabolites, polyamines, trimethylamine-N-oxide, formate, and hydrogen sulfide. These metabolites regulate various cell types in the intestine, leading to an altered intestinal barrier, immunity, chronic inflammation, and tumorigenesis. The physical, chemical, and metabolic properties of these metabolites along with their distinct functions to trigger host receptors appear to largely determine their effects in regulating CRC development. In this review, we will discuss the current advances in our understanding of the major CRC-regulating microbial metabolites, focusing on their production and interactive effects on immune responses and tumorigenesis in the colon.
Keywords: Colonic neoplasms; Inflammation; Intestine; Microbial metabolites; Microbiome.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.Eksp Klin Gastroenterol. 2016 Jul;12(12):6-29. Eksp Klin Gastroenterol. 2016. PMID: 29889418 Review. English, Russian.
-
Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.Methods Mol Biol. 2018;1856:35-55. doi: 10.1007/978-1-4939-8751-1_3. Methods Mol Biol. 2018. PMID: 30178245 Review.
-
Microbial metabolites in colorectal tumorigenesis and cancer therapy.Gut Microbes. 2023 Jan-Dec;15(1):2203968. doi: 10.1080/19490976.2023.2203968. Gut Microbes. 2023. PMID: 37095682 Free PMC article. Review.
-
Gut microbiome in tumorigenesis and therapy of colorectal cancer.J Cell Physiol. 2023 Jan;238(1):94-108. doi: 10.1002/jcp.30917. Epub 2022 Nov 21. J Cell Physiol. 2023. PMID: 36409765 Review.
-
Novel insights into microbiome in colitis and colorectal cancer.Curr Opin Gastroenterol. 2017 Nov;33(6):422-427. doi: 10.1097/MOG.0000000000000399. Curr Opin Gastroenterol. 2017. PMID: 28877044 Free PMC article. Review.
Cited by
-
Interactions between the tumor microbiota and breast cancer.Front Cell Infect Microbiol. 2025 Jan 24;14:1499203. doi: 10.3389/fcimb.2024.1499203. eCollection 2024. Front Cell Infect Microbiol. 2025. PMID: 39926112 Free PMC article. Review.
-
Effect of Probiotics on Improving Intestinal Mucosal Permeability and Inflammation after Surgery.Gut Liver. 2025 Mar 15;19(2):207-218. doi: 10.5009/gnl240170. Epub 2024 Sep 27. Gut Liver. 2025. PMID: 39327843 Free PMC article.
-
Prebiotic Potential of Dietary Polyphenols in Colorectal Cancer Immunomodulation.Foods. 2025 Jul 7;14(13):2392. doi: 10.3390/foods14132392. Foods. 2025. PMID: 40647144 Free PMC article. Review.
-
Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review).Int J Oncol. 2024 Jul;65(1):73. doi: 10.3892/ijo.2024.5661. Epub 2024 Jun 7. Int J Oncol. 2024. PMID: 38847233 Free PMC article. Review.
-
Does postcholecystectomy increase the risk of colorectal cancer?Front Microbiol. 2023 Jun 22;14:1194419. doi: 10.3389/fmicb.2023.1194419. eCollection 2023. Front Microbiol. 2023. PMID: 37426004 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous